About Event

This year’s focus is Diabetic Kidney Disease during and after COVID-19. As an attendee you will get inside access to updates, clinical breakthroughs, healthcare issues and concerns from the leading doctors, specialists, researchers and professionals studying Diabetic Kidney Disease (DKD).

A dynamic day of keynote speakers that include medical professionals and kidney disease transplant specialists; educational workshops, resources that are available, plus sources for information and support from people and companies who understand the needs of diabetic and renal patients.

July 2019, 2020, kidney disease was finally recognized and made a national healthcare priority in America by Executive Order of the President of the United States.

Keynote Speakers

LaTonya J. Hickson, M.D., Mayo Clinic

Rebecca Craig-Schapiro, M.D. Ph.D, New York-Presbyterian/Weill Cornell Medical

Dr. Jose Manuel Monroy-Trujillo, Johns Hopkins

Aamer H. Jamali, MD, FACC, FSCAI, Interventional Cardiology Medical Group

Zahi E. Nassoura, M.D., FACS, San Fernando Valley Vascular Group

Mavis Williams Billips, MD, MPH, City of Angels Dermatology

Nina Abiera, MSW, LCSW, NSW-C, MPA, Kaiser Permanente/US Renal

Thomas Mone, CEO OneLegacy

Shelly Greve RN, BSN, LLUMC- Transplant Institute

Time/Schedule

 
 
8:01AM
Introduction to 2021 Kidney Disease Impact Conference
 

Topic: Kidney Transplantation in the Era of COVID-19

Speaker: Rebecca Craig-Schapiro, M.D. Ph.D, NewYork-Presbyterian/Weill Cornell Medical

 
 

Topic: The Potential of Cell-based Regenerative Therapy for Diabetic Kidney Disease

Speaker: LaTonya J. Hickson, MD, MAYO CLINIC

 
 

Topic: Vascular Disease and its effects from diabetic kidney disease

Speaker: Zahi E. Nassoura, M.D., FACS, San Fernando Valley Vascular Group

 
 

Topic: Cardiovascular Disease associated. with DKD

Speaker: Aamer H. Jamali, MD, FACC, FSCAI, Interventional Cardiology Medical Group

 

Topic: Organ Donation and COVID / Donation rates and trends overall and by race/ethnicity here and across the country

Speaker: Tom Mone CEO, OneLegacy

 
 

Topic: Use of SGLT2 inhibitors and Chronic Kidney Disease

Speaker: Jose Manuel Monroy Trujillo, M.D., John Hopkins Medicine

 

Lunch Break

 
 

Topic: Dermatological lesions in Kidney transplant patients

Speaker: Mavis Williams Billips, MD, MPH, City of Angels Dermatology

 

Topic: Life Care Planning

Speaker: Nina Abiera LCSW, MPA, NSW-C, Kaiser Permanente/US Renal

 

Topic: Post Transplant DKD era Covid-19

Speaker: Shelly Greve RN, BSN, Supervisor, Transplant Coordinator, LLUMC- Transplant Institute

 
 
 
Panel Discussion
 

Speaker: Aamer H. Jamali, MD, FACC, FSCAI, Interventional Cardiology Medical Group

Speaker: Jose Manuel Monroy Trujillo, M.D., John Hopkins Medicine

Prices

Caregivers & Renal Community

$49/per

Caregivers

Renal Community

and others...

 

Register

Medical & Healthcare Professionals

$60/per

Social Workers

Nurses

Dietician's

Dialysis Technicians

Medical Directors

Administrators and Organization Managers

and more...

 

Register

Kidney Patients & Survivors

$15/per

Transplanted

Currently on Dialysis

Diagnosis Kidney Disease

 

Register

More About Event...

Who should attend: 
Renal Patients, Caregivers, Social Workers, Nurses, Dieticians, Dialysis Technicians, Medical Directors, Administrators and Organization Managers, Healthcare Workers, Caregivers, Physicians and Healthcare professionals. Concerned friends, affected families, the community, or anyone interested in learning more about kidney disease and dialysis are also welcome. 

The impact of COVID-19 on diabetes, dialysis and kidney disease:
COVID-19 has become the greatest challenge the world currently faces. Truly a matter of life and death, the pandemic has severely impacted our lives, our healthcare systems, hospitals and medical facilities, healthcare professionals, medical research, governments, world markets, the economy and humanity itself. Many new medical questions have arisen such as, how does this affect surgeries and transplants? What new or additional precautions and procedures are necessary for dialysis, blood transfusions and blood draws? How has COVID-19 affected Diabetes and Kidney Disease patients, dialysis centers, treatment and medical procedures?

Focus on Diabetic Kidney Disease during COVID-19:
In response to many new questions and concerns, the 2021 Kidney Disease Impact Conference will focus on updates, recent information, clinical breakthroughs and healthcare issues, by bringing greater awareness about Diabetic Kidney Disease (DKD) during and after COVID-19.

A virtual healthcare conference streaming internationally:
For health and safety reasons due to COVID-19, the 2021 Kidney Disease Impact Conference has progressed from an in-person conference with national webinar support to a 100% virtual, streaming event. This has greatly expanded and opened-up the opportunity for outreach to renal communities globally. Streaming as a one-day healthcare conference, the event will bring together medical and healthcare professionals, patients, caregivers and anyone interested in learning more about kidney disease for an incredible educational opportunity and full day series of necessary and informative webinars.

Please contact info@kidneysquestfoundation.org if you have any questions about the conference.

Session Topics: Diabetes and Kidney Disease, Vascular, Heart Disease, Transplants, Diabetes and APKD, Community Support for DKD Awareness & Prevention, Centers for Disease Control and Prevention, Clinical Trials & DKD, Dermatology & Post Transplant Patients, Resources & Support.

Thank you to our Sponsors!

This educational activity is supported by a grant from the American Association of Kidney Patients’ Jenny Kitsen Patient Safety Award Endowment.